More tools:Markets·Screener·Research·Chat

Traws Pharma, Inc. Common Stock (TRAW) Financial Statements

Traws Pharma, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T921M7
XNAS · usd
0.55▲ 0.00 (0.44%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.55
Day's Range0.55 – 0.59
52-Week Range0.43 – 3.27
Volume49.3K
Avg Volume89.8K
Share Statistics
Shares Outstanding
Employees7
ExchangeXNAS
Listed2013-07-25
Share count as of August 12, 2026

No financial data found for TRAW

Try a different ticker. We may not have processed this company's filings yet.

Key questions about Traws Pharma, Inc. Common Stock (TRAW)
What is Traws Pharma, Inc. Common Stock's Market Cap?
Traws Pharma, Inc. Common Stock's Market Cap is $8.5M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Enterprise Value?
Traws Pharma, Inc. Common Stock's Enterprise Value is $3.5M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Price / Sales?
Traws Pharma, Inc. Common Stock's Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EV / Revenue?
Traws Pharma, Inc. Common Stock's EV / Revenue is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EV / EBITDA?
Traws Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Revenue (TTM)?
Traws Pharma, Inc. Common Stock's Revenue (TTM) is $2.8M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Net Income (TTM)?
Traws Pharma, Inc. Common Stock's Net Income (TTM) is -$21.6M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EBITDA?
Traws Pharma, Inc. Common Stock's EBITDA is -$21.4M, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's Diluted EPS (TTM)?
Traws Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.40, based on as-reported figures from SEC (XBRL) filings.
What is Traws Pharma, Inc. Common Stock's EBITDA Margin?
Traws Pharma, Inc. Common Stock's EBITDA Margin is -766.9%, based on as-reported figures from SEC (XBRL) filings.